UK markets closed

FSD Pharma Inc. (HUGE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4400+0.0038 (+0.87%)
As of 11:45AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,068
3,859
6,911
6,328
7,833
Selling general and administrative
17,333
13,205
15,981
23,370
18,110
Total operating expenses
26,889
19,570
27,430
33,744
30,601
Operating income or loss
-26,889
-19,570
-27,430
-33,744
-30,601
Interest expense
77.892
0.299
48.822
69.404
235.581
Total other income/expenses net
181.927
553.462
407.036
-126.184
2,381
Income before tax
-26,718
-18,231
-26,704
-33,938
-28,452
Income from continuing operations
-26,718
-18,231
-26,704
-33,938
-28,452
Net income
-23,806
-17,902
-23,607
-35,285
-31,800
Net income available to common shareholders
-23,806
-17,902
-23,607
-35,285
-31,800
Basic EPS
-1.01
-0.46
-0.61
-1.01
-2.64
Diluted EPS
-1.01
-0.46
-0.61
-1.01
-2.64
Basic average shares
34,945
39,589
38,732
34,945
12,044
Diluted average shares
34,945
39,589
38,732
34,945
12,044